Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2014 13
2015 10
2016 11
2017 5
2018 12
2019 7
2020 9
2021 7
2022 3
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam study.
Mehmandoost S, Mirzazadeh A, Karamouzian M, Khezri M, Sharafi H, Shahesmaeili A, Maghsoudi SH, Ghalekhani N, Tavakoli F, Bazrafshani MS, Shokoohi M, Aghaali N, Haghdoost AA, Sharifi H. Mehmandoost S, et al. Among authors: sharafi h. Subst Abuse Treat Prev Policy. 2023 Nov 29;18(1):72. doi: 10.1186/s13011-023-00583-6. Subst Abuse Treat Prev Policy. 2023. PMID: 38031110 Free PMC article.
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Bakouni H, Sharafi H, Bahremand A, Drouin S, Ziegler D, Bach P, Le Foll B, Schütz CG, Tardelli V, Ezard N, Siefried K, Jutras-Aswad D. Bakouni H, et al. Among authors: sharafi h. Drug Alcohol Depend. 2023 Dec 1;253:111018. doi: 10.1016/j.drugalcdep.2023.111018. Epub 2023 Nov 4. Drug Alcohol Depend. 2023. PMID: 37979478 Review.
Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study: Associations entre le traitement avec la buprénorphine/naloxone et avec la méthadone et l'utilisation de substances non opioïdes dans le trouble lié à l'usage d'opioïdes de type sur ordonnance : analyses secondaires de l'étude OPTIMA.
Bakouni H, Sharafi H, Drouin S, Fortin R, Marsan S, Brissette S, Socias ME, Le Foll B, Lim R, Jutras-Aswad D. Bakouni H, et al. Among authors: sharafi h. Can J Psychiatry. 2024 Apr;69(4):252-263. doi: 10.1177/07067437231210796. Epub 2023 Oct 30. Can J Psychiatry. 2024. PMID: 37899716 Clinical Trial.
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sharafi H, Bakouni H, McAnulty C, Drouin S, Coronado-Montoya S, Bahremand A, Bach P, Ezard N, Le Foll B, Schütz CG, Siefried KJ, Tardelli VS, Ziegler D, Jutras-Aswad D. Sharafi H, et al. Addiction. 2024 Feb;119(2):211-224. doi: 10.1111/add.16347. Epub 2023 Oct 25. Addiction. 2024. PMID: 37880829 Review.
Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.
Khezri M, Mirzazadeh A, Shokoohi M, Sharafi H, Ghalekhani N, Tavakoli F, Mehmandoost S, Mousavian G, Imani M, Kakavand-Ghalehnoei R, Komasi A, Gouya MM, Haghdoost AA, McFarland W, Karamouzian M, Sharifi H. Khezri M, et al. Among authors: sharafi h. Drug Alcohol Depend. 2023 Feb 1;243:109751. doi: 10.1016/j.drugalcdep.2022.109751. Epub 2023 Jan 2. Drug Alcohol Depend. 2023. PMID: 36621200 Free PMC article.
An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study.
Mirzazadeh A, Hosseini-Hooshyar S, Shahesmaeili A, Sharafi H, Shafiei M, Zarei J, Mousavian G, Tavakoli F, Ghalekhani N, Shokoohi M, Khezri M, Mehmandoost S, Shojaei MR, Karamouzian M, Briceno A, Morris MD, Alavian SM, Haghdoost AA, Sharifi H, Page KA. Mirzazadeh A, et al. Among authors: sharafi h. Int J Drug Policy. 2022 Apr;102:103580. doi: 10.1016/j.drugpo.2022.103580. Epub 2022 Jan 21. Int J Drug Policy. 2022. PMID: 35074607 Free PMC article.
80 results